[News article] Corruption of health care delivery system? — ScienceDaily

Corruption of health care delivery system? — ScienceDaily.

From the 14 October 2014 article

he foundation of evidence-based research has eroded and the trend must be reversed so patients and clinicians can make wise shared decisions about their health, say Dartmouth researchers in the journal Circulation: Cardiovascular Quality and Outcomes.

Drs. Glyn Elwyn and Elliott Fisher of The Dartmouth Institute for Health Policy & Clinical Practice are authors of the report in which they highlight five major problems set against a backdrop of “obvious corruption.” There is a dearth of transparent research and a low quality of evidence synthesis. The difficulty of obtaining research funding for comparative effectiveness studies is directly related to the prominence of industry-supported trials: “finance dictates the activity.”

The pharmaceutical industry has influenced medical research in its favor by selective reporting, targeted educational efforts, and incentivizing prescriber behavior that influences how medicine is practiced, the researchers say. The pharmaceutical industry has also spent billions of dollars in direct-to-consumer advertising and has created new disease labels, so-called disease-mongering, and by promoting the use of drugs to address spurious predictions.

Another problem with such studies is publication bias, where results of trials that fail to demonstrate an effect remain unpublished, but trials where the results are demonstrated are quickly published and promoted.

…

English: Example of promotional “freebies” given to physicians by pharmaceutical companies (Photo credit: Wikipedia)

 

The authors offer possible solutions:

Related articles

• Corruption of the health care delivery system
• Corruption of the Health Care Delivery System
• Corruption of health care delivery system?

[Research article]Morality Rebooted: Exploring Simple Fixes to Our Moral Bugs

From the abstract

Morality Rebooted: Exploring Simple Fixes to Our Moral Bugs

Ting Zhang ,Harvard Business School

Francesca Gino ,Harvard University – Harvard Business School

Max H. Bazerman ,Harvard Business School – Negotiations, Organizations and Markets Unit
April 21, 2014

Harvard Business School NOM Unit Working Paper No. 14-105

Abstract:      

Ethics research developed partly in response to calls from organizations to understand and solve unethical behavior. Departing from prior work that has mainly focused on examining the antecedents and consequences of dishonesty, we examine two approaches to mitigating unethical behavior: (1) values-oriented approaches that broadly appeal to individuals’ preferences to be more moral, and (2) structure-oriented approaches that redesign specific incentives, tasks, and decisions to reduce temptations to cheat in the environment. This paper explores how these approaches can change behavior. We argue that integrating both approaches while avoiding incompatible strategies can reduce the risk of adverse effects that arise from taking a single approach.